DORIAN

Developmental Origins of Healthy and Unhealthy Ageing: The Role of Maternal Obesity

 Coordinatore CONSIGLIO NAZIONALE DELLE RICERCHE 

 Organization address address: Piazzale Aldo Moro 7
city: ROMA
postcode: 185

contact info
Titolo: Dr.
Nome: Michela
Cognome: Rial
Email: send email
Telefono: +39 050 3152101
Fax: +39 050 315 2095

 Nazionalità Coordinatore Italy [IT]
 Sito del progetto http://www.dorian-fp7.eu/
 Totale costo 3˙863˙873 €
 EC contributo 2˙999˙973 €
 Programma FP7-HEALTH
Specific Programme "Cooperation": Health
 Code Call FP7-HEALTH-2011-two-stage
 Funding Scheme CP-FP
 Anno di inizio 2012
 Periodo (anno-mese-giorno) 2012-01-01   -   2014-12-31

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    CONSIGLIO NAZIONALE DELLE RICERCHE

 Organization address address: Piazzale Aldo Moro 7
city: ROMA
postcode: 185

contact info
Titolo: Dr.
Nome: Michela
Cognome: Rial
Email: send email
Telefono: +39 050 3152101
Fax: +39 050 315 2095

IT (ROMA) coordinator 799˙994.00
2    SAMFUNDET FOLKHALSAN I SVENSKA FINLAND RF

 Organization address address: TOPELIUSGATAN 20
city: HELSINGFORS
postcode: 250

contact info
Titolo: Mr.
Nome: Christer
Cognome: Holmström
Email: send email
Telefono: +358 9 31 5000
Fax: +358 9 3155101

FI (HELSINGFORS) participant 600˙000.00
3    THE UNIVERSITY OF EDINBURGH

 Organization address address: OLD COLLEGE, SOUTH BRIDGE
city: EDINBURGH
postcode: EH8 9YL

contact info
Titolo: Ms.
Nome: Angela
Cognome: Noble
Email: send email
Telefono: +44 131 650 9024
Fax: +44 131 651 4028

UK (EDINBURGH) participant 350˙000.00
4    TURUN YLIOPISTO

 Organization address address: YLIOPISTONMAKI
city: TURUN YLIOPISTO
postcode: 20014

contact info
Titolo: Dr.
Nome: Eliisa
Cognome: Särkilahti
Email: send email
Telefono: +358 2 3336155
Fax: +358 2 3336363

FI (TURUN YLIOPISTO) participant 349˙993.00
5    BIOMOL-INFORMATICS SL

 Organization address address: CALLE FARADAY -Parque Cientifico- 7
city: MADRID
postcode: 28049

contact info
Titolo: Ms.
Nome: Milagros
Cognome: Ruiz Del Peso
Email: send email
Telefono: +34 918279767
Fax: +34 911880756

ES (MADRID) participant 210˙000.00
6    MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN E.V.

 Organization address address: Hofgartenstrasse 8
city: MUENCHEN
postcode: 80539

contact info
Titolo: Mr.
Nome: Hartmut
Cognome: Lingner
Email: send email
Telefono: +49 89 30622330
Fax: +49 89 30622372

DE (MUENCHEN) participant 200˙000.00
7    ISTITUTO SUPERIORE DI SANITA

 Organization address address: Viale Regina Elena 299
city: ROMA
postcode: 161

contact info
Titolo: Dr.
Nome: Rosa
Cognome: Martoccia
Email: send email
Telefono: +39 06 49902688
Fax: +39 06 49903007

IT (ROMA) participant 199˙986.00
8    GABO:MI GESELLSCHAFT FUR ABLAUFORGANISATION:MILLIARIUM MBH & CO KG GAB O

 Organization address address: Oskar-von-Miller-Ring 29
city: MUENCHEN
postcode: 80333

contact info
Titolo: Ms.
Nome: Birgit
Cognome: Fuchs
Email: send email
Telefono: +49 89 28810414
Fax: +49 89 28810420

DE (MUENCHEN) participant 195˙000.00
9    European Association for the Study of Obesity

 Organization address address: High Street 113-119
city: Hampton Hill
postcode: TW12 1NJ

contact info
Titolo: Mr.
Nome: Euan
Cognome: Woodward
Email: send email
Telefono: +44 20 87832256
Fax: +44 20 8979 6700

UK (Hampton Hill) participant 80˙000.00
10    Mouvement Mondial des Meres - Europe

 Organization address address: Avenue Nestor Plissart 8
city: Bruxelles
postcode: 1040

contact info
Titolo: Ms.
Nome: Marie-Claude
Cognome: Hayoit De Termicourt
Email: send email
Telefono: +32 475 33 61 35

BE (Bruxelles) participant 15˙000.00

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

offspring    cvd       maternal    ageing    population    world    life    obesity    risk    disease    genetic    health   

 Obiettivo del progetto (Objective)

'Europe has the highest proportion of elderly people in the world. Cardiovascular disease (CVD), type 2 diabetes (T2D), sarcopenia and cognitive decline frequently coexist in the same aged individual, sharing common early risk factors and being mutually reinforcing. Obesity is a main health concern in the world. In the EU one-third of women of reproductive age are overweight and 20% are obese, a prevalence predicted to double in the next decade. There is growing evidence that maternal obesity increases the long term risk of CVD, T2D and neurodegenerative morbidity in the offspring. This project will clarify if and to what extent maternal obesity leads to premature and unhealthy ageing, by causing early, i.e. pre-/perinatal metabolic and genetic vulnerability, starting from insulin resistance and glucocorticoid exposure, leading to oxidative-stress, telomere/DNA damage, epigenetic changes, interacting with genetic and environmental variability, resulting in altered gene expression/repair, and ultimately in disease during life and pathological ageing. We will investigate the postulated mechanisms during pregnancy and development, their life long consequences in animal models and in large human cohorts followed from prenatal life until ageing, and the possibility to intervene when the condition is still reversible. Surrogate markers to estimate early risk and monitor progression-regression will be defined. This project will comprehensively address the expected impacts listed in the work programme HEALTH.2011.2.2.2-2 targeting the improvement of health and healthy ageing of a broad/broadening European population. The participation of a research intensive SME and European NGOs guarantees success in biomarker discovery-innovation and in dissemination-public preventive programs. The scientific excellence and complementariness of the partners and the relevance of the target health problem will make a highly significant impact on the European policy and research in this area.'

Introduzione (Teaser)

Comprehending how maternal obesity could influence offspring health could improve the overall health of the European population. For this purpose, European scientists have set out to identify which early developmental factors determine our health and ageing.

Altri progetti dello stesso programma (FP7-HEALTH)

EUCELLEX (2013)

Cell-based regenerative medicine: new challenges for EU legislation and governance

Read More  

SYBARIS (2009)

Finding biomarkers of anti-microbial drug resistance via a systems biology analysis of fungal pathogen interactions with the human immune system

Read More  

CAMBRELLA (2010)

CAMbrella – A pan-European research network for Complementary and Alternative Medicine (CAM)

Read More